Christopher Andrew Nichols co-founded Bioscience Global with one bold vision: to provide innovative health solutions that address the most prevalent and challenging health problems confronting people worldwide today.

This meant creating innovative, clinically proven, and cost-effective solutions capable of rapid global distribution.

An alumnus of Simon Fraser University (Canada), Christopher earned his BSc in Biology with distinction, paving the way for a successful career in senior leadership with global companies like Labatt Breweries (AB InBev), Coca-Cola, and Molson Coors. Although he thrived in these roles, Christopher felt a calling to make a deeper impact in the biotech space. Christopher joined Ecovatec Solutions Inc. 18 months after its founding to assist in the science of extracting phosvitin, a vital step in the company’s development.

Christopher’s mission to create impactful global health solutions became personal as his wife, Lisa Nichols, continued to struggle with the symptoms of anemia, despite taking high-dose iron supplements as prescribed. Her iron levels remained consistently low, and the unpleasant side effects seemed to worsen.

Determined to find a better solution, Christopher focused his expertise on developing a clinically effective iron therapeutic with ultra-high efficacy, ultra-low dosing, and no side effects.

His efforts resulted in the groundbreaking development of PVP-437, the patent-pending technology that isolates, then fractionates, pure phosvitin at a commercial scale. PVP stands for phosvitin peptides, the highly concentrated “iron-magnet peptides” found in eggs. The innovation is known as Ferravitin™, or PVP-bonded iron.

The scientific community hailed PVP as a significant technological achievement in biotechnology. When PVP is bonded to iron, it increases iron absorption by 813 %, leaves virtually no unabsorbed iron in the gut to cause side effects, and rapidly restores iron levels with ultra-low dosing.

After just one month of taking Ferravitin™, Lisa’s ferritin levels rose significantly, without the gut-disrupting side effects of traditional iron supplements. Her anemia symptoms vanished, and her quality of life was transformed.

Inspired by this life-changing effect, Christopher put a laser focus on the unmet needs of women, men, and children worldwide who face similar struggles with iron deficiency and its debilitating symptoms.

Committed to making a positive difference, Bioscience Global has launched the first and only Ferravitin™ products in the US. These include Rapid Restoration™, Daily Maintenance™, and Pregnancy Formula™—all offering a gentler, more effective way to improve and sustain healthy iron levels.

Today Bioscience Global continues the mission Christopher set at the beginning: delivering innovative, scientifically proven solutions that create healthier, more active lives for people around the world. It starts with Ferravitin™ and won't stop until global health issues no longer exist.